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Abstract
Background: Injuries to articular cartilage result in the development of lesions that form on the surface of the
cartilage. Such lesions are associated with articular cartilage degeneration and osteoarthritis. The typical injury
response often causes collateral damage, primarily an effect of inflammation, which results in the spread of lesions
beyond the region where the initial injury occurs.
Results and discussion: We present a minimal mathematical model based on known mechanisms to investigate
the spread and abatement of such lesions. The first case corresponds to the parameter values listed in Table 1,
while the second case has parameter values as in Table 2. In particular we represent the “balancing act” between
pro-inflammatory and anti-inflammatory cytokines that is hypothesized to be a principal mechanism in the
expansion properties of cartilage damage during the typical injury response. We present preliminary results of in
vitro studies that confirm the anti-inflammatory activities of the cytokine erythropoietin (EPO). We assume that the
diffusion of cytokines determine the spatial behavior of injury response and lesion expansion so that a reaction
diffusion system involving chemical species and chondrocyte cell state population densities is a natural way to
represent cartilage injury response. We present computational results using the mathematical model showing that
our representation is successful in capturing much of the interesting spatial behavior of injury associated lesion
development and abatement in articular cartilage. Further, we discuss the use of this model to study the possibility
of using EPO as a therapy for reducing the amount of inflammation induced collateral damage to cartilage during
the typical injury response.
Conclusions: The mathematical model presented herein suggests that not only are anti-inflammatory cy-tokines,
such as EPO necessary to prevent chondrocytes signaled by pro-inflammatory cytokines from entering apoptosis,
they may also influence how chondrocytes respond to signaling by pro-inflammatory cytokines.
Reviewers: This paper has been reviewed by Yang Kuang, James Faeder and Anna Marciniak-Czochra.
Background
Articular cartilage is composed of cells known as chon-
drocytes. Mechanical stress and injury is known to kill
(via necrosis) chondrocytes and results in the formation
of lesions on the cartilage surface [1-4]. The limited
capacity of chondrocytes to self-repair, together with
certain aspects of the typical injury response such as
inflammation, can cause the spread of lesions and devel-
opment of osteoarthritis. Recent research [5] suggests
that inflammatory cytokines such as tumor necrosis fac-
tor a (TNF-a) play a significant role in causing the
spread of cartilage lesions. Anti-inflammatory cytokines
such as erythropoietin (EPO) play an antagonistic role
to TNF-a, limiting the area over which a lesion can
spread by counteracting some of the effects of inflam-
mation [5]. Moreover, the authors in [5] describe the
potential use of EPO as a therapy for cartilage injury
and lesion abatement
The full clinical implementation of an EPO derived
therapy for osteoarthritis may be a difficult task. One
initial step is to establish experimentally that EPO sup-
presses inflammation in vitro. The potential for EPO to
suppress catabolic and inflammatory responses of chon-
drocytes to various alarmins, i.e. molecules that trigger
the innate immune response, was explored in a cell cul-
ture model (Figure 1). Bovine articular chondrocytes in
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Table of Parameter Values Corresponding to Simulations in Figure 5
Parameter Value Units Reason
DR 0.1
cm2
day
Determined from [13]
DM 0.05
cm2
day
Determined from [13]
DF 0.05
cm2
day
Determined from [13]
DP 0.005
cm2
day
Determined from [13]
δR 0.01
1
day
Approximated
δM 0.6
1
day
Approximated
δF 0.6
1
day
Approximated
δP 0.0087
1
day
Approximated
δU 0.0001
1
day
Approximated
sR 0.0001
micromolar · cm2
day · cells
Approximated
sM 0.00001
micromolar · cm2
day · cells
Approximated
sF 0.0001
micromolar · cm2
day · cells
Approximated
sP 0
micromolar · cm2
day · cells
Case with no anti-inflammatory response
Λ 10 micromolar Approximated
lR 10 micromolar Approximated
lM 10 micromolar Approximated
lF 10 micromolar Approximated
lP 10 micromolar Approximated
a 0
1
day
Case with no anti-inflammatory response
b1 100
1
day
Approximated
Β2 50
1
day
Approximated
g 10
1
day
Approximated
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Page 2 of 15serum-free culture were pre-treated with EPO and then
exposed to alarmins in the form of cell lysates or the 29
kDa fibronectin fragment (Fn-f). Interleukin-1b (IL-1b)
was used as a control. Cell lysates were made by
repeated freeze-thawing of excess cells from the same
culture. Culture media were collected for immunoblot
analysis of matrix metalloproteinase-3 (MMP-3) and A
disintegrin and metalloproteinase with thrombospondin
motifs 5 (ADAMTS-5). Cell layers were extracted for
analysis of nuclear factor B( N F - B) and inducible
nitric oxide synthase (iNOS). The results revealed that
lysates, Fn-f, and IL-1b induced NF-Bp h o s p h o r y l a t i o n
(Figure 1A). Fn-f, and IL-1b but not lysates also induced
iNOS, MMP-3 and ADAMTS-5 expression (Figure 1B,
C, D). In the case of NF- B, EPO treatment blocked
activation by lysates, but not by Fn-f or IL-1b. EPO also
dramatically reduced iNOS, MMP-3, and ADAMTS-5
expression in response to Fn-f and IL-1b. These results
underscore the ability of EPO to counter injury effects
on multiple pathways.
Figure 2 illustrates the balance between pro-inflamma-
tory (e.g. TNF-a) and anti-inflammatory (e.g. EPO)
cytokines during the typical injury response. Damage
due to chemical or mechanical stress initiates produc-
tion of alarmins, such as damage associated molecular
pattern molecules (DAMPs) [5-7]. These alarmins trig-
ger production of pro-inflammatory cytokines such as
TNF-a by cells near the initial injury site (see (b) in fig-
ure 2) [5]. Thus there is a penumbra ((c) in figure 2) of
“sick” cells formed at the boundary of the initial injury
as a result of inflammation. While still viable, these cells
are at risk of dying themselves due to the presence of
the pro-inflammatory cytokines, resulting in the spread
of injury as shown in (d)-(e) in figure 2. However, cells
far enough from the injury are able to produce anti-
inflammatory cytokines such as EPO to check the
spread of injury and promote healing. This is shown
(d*)-(e*) in figure 2. It is also suggested in [5] that TNF-
a acts in such a way to limit EPO signaling. Thus there
is a critical balance between pro-inflammatory and anti-
inflammatory cytokines which determines the spreading
properties of an articular cartilage lesion associated with
injury. Moreover, the authors in [5] suggest that intro-
duction of exogeneous EPO at an early time after an
initial injury could be an effective therapy for minimiz-
ing the amount of collateral damage to cartilage that
occurs as a result of inflammation.
The goal of this work is to study via mathematical
modeling the EPO/TNF-a interaction described above,
and in particular to provide a conceptual framework for
a truly mechanistic understanding of some aspects of
cartilage injury closely related to lesion expansion.
Herein we develop a model capable of simulating the
scenario illustrated in figure 2. Moreover, the model is
developed as a potential for studying the use EPO or
other anti-inflammatory cytokines as a therapy for lesion
abatement. The type of model, and in particular the one
described below, in this article is of value as it provides
a link between observed phenomena and the mechan-
isms involved in driving that phenomena. Models such
as those presented below can also help to generate
hypotheses and suggest experiments or fundamental
quantities to be measured. More practically, mathemati-
cal modeling such as we use in this paper could provide
quick and inexpensive initial screening of potential
therapies.
Methods
In this section we describe the mathematical model
developed to represent the biological interactions of
chondrocytes and cytokines described in [5]. We aim for
a minimal model based on known mechanisms consid-
ered to be the dominant factors in articular cartilage
lesion abatement. By a minimal model we mean one in
which the removal of any component results in behavior
that is inconsistent with the typical injury responses in
cartilage as discussed in [5]. We note that the model
described below can be expanded or modified to include
further interactions as new results from experiment and
observation dictate. In particular, further chemical path-
ways such as interleukin-1 b (IL1-b) can easily be incor-
porated if necessary. The chemical species included
Table 1 Model Parameter Values for Results in Figure 5 (Continued)
ν 0.5
1
day
Approximated
μSA 1
1
day
Approximated
μDN 0.5
1
day
Approximated
τ1 0.5 days Taken from [5]
τ2 1 days Taken from [5]
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Page 3 of 15Table 2 Model Parameter Values for Results in Figure 6
Table of Parameter Values Corresponding to Simulations in Figure 6
Parameter Value Units Reason
DR 0.1 cm2
day
Determined from [13]
DM 0.05 cm2
day
Determined from [13]
DF 0.05 cm2
day
Determined from [13]
DP 0.005 cm2
day
Determined from [13]
δR 0.01 1
day
Approximated
δM 0.6 1
day
Approximated
δF 0.6 1
day
Approximated
δP 0.0087 1
day
Approximated
δU 0.0001 1
day
Approximated
sR 0.0001 micromolar · cm2
day · cells
Approximated
sM 0.00001 micromolar · cm2
day · cells
Approximated
sF 0.0001 micromolar · cm2
day · cells
Approximated
sP 0.001 micromolar · cm2
day · cells
Approximated
Λ 10 micromolar Approximated
lR 10 micromolar Approximated
lM 10 micromolar Approximated
lF 10 micromolar Approximated
lP 10 micromolar Approximated
a 10 1
day
Approximated
b1 100 1
day
Approximated
b2 50 1
day
Approximated
g 10 1
day
Approximated
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Page 4 of 15Table 2 Model Parameter Values for Results in Figure 6 (Continued)
ν 0.5 1
day
Approximated
μSA
1 1
day
Approximated
μDN
0.5 1
day
Approximated
τ1 0.5 days Taken from [5]
τ2 1 days Taken from [5]
Figure 1 Effects of EPO on chondrocyte responses to alarmins and IL-1 beta. Immunoblot analyses are shown for phospho- and total
nuclear factor kappa-B (NF-kB), a pro-inflammatory transcription factor (A), inducible nitric oxide synthase (iNOS), a catabolic signaling factor (B),
matrix metalloproteinase-3 (MMP-3) (C), and a disintegrin and metalloproteinase domain with thrombospondin repeats (ADAMTS-5) (D), which
cause cartilage matrix degeneration. Primary cultures of bovine chondro-cytes (1 × 10
6 cells/well) were treated with 10 IU/ml EPO for 24 hours,
then challenged for an additional 24 hours with the indicated concentrations of purified 29 kDa fibronectin fragment, a known extracellular
matrix DAMP, or IL-1b, a pro-inflammatory cytokine, or cell lysates containing multiple cellular DAMPS. EPO treatment suppressed catabolic
responses induced by all three treatments.
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Page 5 of 15below are chosen for their functionality that is their
action on chondrocytes during injury response. Hence
they can be replaced with any other chemical species
whose effects on chondrocytes are functionally the
same. The chondrocyte cell states described below
represent the biological actio n so ft h ec e l l si nr e s p o n s e
to signaling by a particular cytokine during the typical
injury response. These actions are assumed to be analo-
gous to those of other cell types, for which aspects of
innate immune response, such as local inflammation
considered in this paper, are well established.
We consider a population of chondrocytes fixed in
matrix, which is typical of articular cartilage. Sub-popu-
lations of chondrocytes are assumed to exist in different
states corresponding to the chemical signals being
received by the cells during injury response. Figure 3
shows the states in which subpopulations of
chondrocytes may exist. We refer to the normal state of
a subpopulation of chondrocytes as the healthy state.
We denote by C the population density (cells per unit
area) of healthy chondrocytes at a given time and loca-
tion. As a result of inflammation and injury healthy
chondrocytes can enter into a “sick” state. Cells in this
state are at risk death (via apoptosis) unless their signal-
ing by TNF-a is somehow limited. We consider two
subpopulations of cells in the sick state. We denote by
ST the population density of cells in the “catabolic”
state. Catabolic cells are chondrocytes that have been
signaled by alarmins and are capable of synthesizing
TNF-a and other cytokines associated with inflamma-
tion. Healthy cells signaled by DAMPs or TNF-a enter
into the catabolic state and begin to synthesize TNF-a
and produce reactive oxygen species (ROS). Catabolic
cells that are signaled by TNF-a express a receptor
Figure 2 Injury response. When a wound occurs DAMPs promote production of TNF-a (b), an initially viable penumbra (yellow in (c)) of cells
becomes EPOR active. These cells are in danger of death which can result in the spread of injury as seen on the left in (d) and (e). However,
EPO can counteract the effects of TNF-a and prevent spread of the lesion (d*) and (e*).
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Page 6 of 15(EPOR) for EPO and make up the subpopulation of sick
cells we refer to as EPOR active. It should be noted that
t h e r ei sat i m ed e l a yo f8 - 1 2h o u r sb e f o r eac e l l
expresses the EPO receptor after being signaled to
become EPOR active [5]. We denote the population
density of EPOR active cells by SA. Since EPOR active
cells express a receptor for EPO, they may switch back
to the healthy state if signaled by EPO. However, as dis-
cussed in [5] TNF-a limits production of EPO. Thus
there is a balance between EPO and TNF-a that deter-
mines the spreading behavior of cartilage lesions. The
catabolic and EPOR active cells together make up the
population of cells forming the penumbra as illustrated
in figure 2. We also consider a “dead” state for subpopu-
lations of chondrocytes. This includes necrotic cells DN
and apoptotic cells DA.W en o t et h a tf o rt h ep u r p o s e s
considered herein that apoptotic cells do not feed back
into the system and thus are not explicitly represented
in the mathematical model. Due to the abrupt nature of
the injury, we assume that the initial injury results in
necrosis of cells at the injury site. Furthermore, we
assume that cell death due to secondary cytokine-
induced injury is strictly through apoptosis. The reason-
i n gh e r ei st h a tn e c r o s i si san o n s p e c i f i ce v e n tt h a t
occurs in cases of severe pathological cell and tissue
damage, whereas secondary cytokine-induced injury cor-
responds with a physiologic form of cell death used to
remove cells in a more orderly and regulated fashion
and there is evidence that often, this is via apoptosis [8].
While these may be simplifying assumption, it is not
entirely clear what type of cell death dominates in
osteoarthritis, and there is some evidence to support
our assumptions [8]. Necrotic cells release alarmins
such as DAMPs that initiate the injury response. Either
catabolic or EPOR active cells become apoptotic if sig-
naled by inflammatory cytokines.
Figure 4 details the chemical signaling and the switch-
ing of chondrocyte cell states represented in the mathe-
matical model presented in the following. An initial
injury creates a population of necrotic cells which
release alarmins (such as DAMPs) [6,7]. We denote by
M the concentration of DAMPs at a given time and
location. The DAMPs signal healthy cells near the injury
to enter the catabolic state resulting in the production
of TNF-a. We denote the concentration of TNF-a at a
given time and location by F. The inflammatory cyto-
kine TNF-a has several effects on the system: It
1. feeds back to continue to switch healthy cells into
the catabolic state,
2. causes catabolic cells to enter the EPOR active
state [5],
3. influences apoptosis of catabolic and EPOR active
cells,
4. degrades extracellular matrix (denoted by U)
which results in increased concentrations of DAMPs,
5. has a limiting effect on production of EPO [5].
C a t a b o l i cc e l l sa l s op r o d u c er e a c t i v eo x y g e ns p e c i e s
(ROS) which influences the production of EPO by
healthy cells. We denote the concentration of ROS at a
given time and location by R. There is a time delay of
20-24 hours before a healthy cell signaled by ROS will
begin to produce EPO.
In developing a mathematical model to represent the
scenario described above we assume that the chemicals
diffuse throughout a domain. This diffusion is essential
in determining the spatial behavior, i.e. the expansion or
abatement of the lesion. Since the chondrocytes are
fixed in the matrix we do not consider cell motility.
First the mathematical model contains four equations
(one for each chemical species) describing the dynamics
Figure 3 States of chondrocytes during stereotypical injury response. Healthy cells (C) become sick. Typically a healthy cell will first become
catabolic (ST) and either enter apoptosis (DA), or become EPOR active (SA). EPOR active cells may be saved by EPO to become healthy once
again, or die (apoptosis).
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Page 7 of 15of the chemical concentrations. These equations are
each of the form:
change in concentration of particular chemical
= diffusion of that chemical
+ production of that chemical by cells in appropriate states
−natural decay of that chemical.
(1)
Next the model consists of four equations for the
population densities of cells in the healthy, catabolic,
EPOR active, and necrotic states. Each of these equa-
tions are of the form:
change in population density of particular cell state
= population density of cells switching into that state due to appropriate signaling
- population density of cells switching out of that state due to appropriate signaling.
(2)
Finally there is an equation corresponding to the
degradation of extracellular matrix by TNF-a which
feeds back into the production of DAMPs.
The model equations for the concentrations of the
chemical species are:
∂tR = ∇·(DR∇R) − δRR + σRST, (3)
∂tM = ∇·(DM∇M) − δMM + σMDN + δUU
F
λF + F
, (4)
∂tF = ∇·(DF∇F) − δFF + σFST, (5)
∂tP = ∇·(DP∇P) − δPP + σPC
R(t − τ2)
λR + R(t − τ2)
 
  + F
.(6)
The equation describing matrix degradation by TNF-a
is:
∂tU = −δUU
F
λF + F
. (7)
We note that the right hand side of this equation
appears in (4) as part of the production of DAMPs as
we have assumed that degraded matrix releases
alarmins.
Figure 4 Signaling involved in cartilage injury response. The occurrence of an injury begins a sequence of chemical productions that
promote the inflammatory response. Lysing (necrotic) cells give off DAMPs (M) resulting in a population of catabolic cells that produce TNF-a
(F) and ROS (R). ROS promotes production of EPO (P) by healthy cells while TNF-a acts to block EPO signaling. Furthermore, TNF-a influences
degradation of extracellular matrix providing another source of DAMPs. The cells switch state according to the signaling by chemicals produced
in response to injury and inflammation. DAMPs and TNF-a drive the C ® ST transition, TNF-a drives the ST ® SA transition, while TNF-a and
DAMPs drive the ST ® DA transition. Finally, EPO drives the SA ® C transition. This figure illustrates the assumptions of the mathematical model
(equations (3-11)). Not shown: DAMPs given off as a result of matrix degradation also influences the switch from healthy to catabolic.
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∂tC = αSA
P
λP + P
− β1C
M
λM + M
H(P − Pc) − β2C
F
λF + F
H(P − Pc), (8)
∂tST = β1C
M
λM + M
H(P − Pc)+β2C
F
λF + F
H(P − Pc) − γST(t − τ1)
F(t − τ1)
λF + F(t − τ1)
− νST
F
λF + F
M
λM + M
,
(9)
∂tSA = γST(t − τ1)
F(t − τ1)
λF + F(t − τ1)
− αSA
P
λP + P
− μSASA
F
λF + F
, (10)
∂tDN = −μDNDN. (11)
In (8) and (9) the function H(·) is given by
H(s)=

1i fs < 0,
0i fs ≥ 0.
(12)
The constant Pc represents a critical level of EPO
above which the effects of DAMPs and TNF-a on
healthy cells is limited.
Based on the diagram in figure 4 and the assumptions
underlying that diagram, one could assume that the func-
tion H(·) is identically one, i.e. H ≡ 1. However, if we take
H ≡ 1 then figure 4 implies, and computational results
confirm, that there is infinite feedback into the system by
alarmins, TNF-a, and catabolic cells. As noted in [5] “the
pro-inflammatory arm of the injury response is inherently
self-amplifying”. This does not allow for lesion abatement
or limitation of secondary pro-inflammatory cytokine
induced injury described in [5]. This suggests that signal-
ing by anti-inflammatory cytokines such as EPO not only
promote the switch from the EPOR active state to the
healthy state but also influences the response of healthy
cells to alarmins and pro-inflammatory cytokines. Thus
the mathematical model suggests that in some way the
anti-inflammatory cytokines limit the switch from the
healthy state to the catabolic state so that there is not an
infinite feedback into the system by alarmins, TNF-a, and
catabolic cells. This is consistent with the observation of
Brines and Cerami on the antagonistic relationship
between TNF-a and EPO, that “each is capable of sup-
pressing the biological activity of the other” [5]. In the
model equations (3-11) we take the function H(·) as in
(12) for convenience. However, there may be a more
appropriate form for the function H(·) that must be deter-
mined through experiment to discover the nature of the
effects that sufficient concentrations of EPO or other anti-
inflammatory cytokines have on healthy chondrocytes.
We note some features of the mathematical model
(equations (3-11)):
1. we have incorporated the time delays for activa-
tion of the EPO receptor and synthesis of EPO (6),
(9),(10),
2. it requires a concentration of TNF-a and DAMPs
together for apoptosis of catabolic cells (see (9)),
3 .a f t e rs o m et i m en e c r o t i cc e l l sd e c a yt oa ni n e r t
state (see (11)) so that there is not a continuous pro-
duction of DAMPs for all time from the initial
injury. This also corresponds to the loss of cartilage
such as is sometimes associated with osteoarthritis.
The specific functional forms appearing in the model
system (equations (3-11)) have been chosen to capture
the critical thresholds and represent the function shapes
qualitatively.
Results and discussion
Using the mathematical model (equations (3-11)) we can
simulate the two scenarios depicted in figure 2. That is,
we can manipulate parameter values that correspond
first to the case where inflammation is not limited by
the presence of anti-inflammatory cytokines (d) and (e)
in figure 2 and second to the case where anti-inflamma-
tory cytokines limit the development of secondary
inflammation induced injury (d*) and (e*) in figure 2.
For the computations and simulations we assume a two
dimensional dimensional domain. Moreover, as depicted
in figure 2 we assume circular symmetry so that changes
only occur in the radial direction. In order to simulate
the injury response we obtain numerical approximations
to the system of partial differential equations (equations
(3-11)). This is done by first employing the scheme for
discretizing the symmetric diffusion operator from
appendix C of [9]. This gives a semi-discrete system of
delay-differential equations which are then solved in
MATLAB using the dde23 code for solving delay-differ-
ential equations. For details on the methods and soft-
ware for solving delay-differential equations see [10-12].
O n eo ft h eg o a l so ft h i sm o d e li st op r o v i d eac o n c e p -
tual framework for a truly mechanistic understanding of
certain aspects of cartilage injury closely related to
lesion expansion. This requires biologists to determine
parameters experimentally, but we need to know the
nature of those parameters before we can go out and
measure them. Since many of the parameter values have
yet to be determined experimentally, we choose those
values to be such that the simulations give quantitatively
reasonable cell populations and chemical concentrations.
We also choose the parameters so that the expansion or
abatement of the lesion occurs over a time period con-
sistent with the experimental results described in [5].
We note that diffusion of the chemical species is the
mechanism which drives the expansion of the lesion in
our model. The diffusion coefficients have been deter-
mined through the methods presented in [13].
First, using the mathematical model (equations (3-11))
we simulate the evolution of chondrocyte population
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Page 9 of 15density (per area, and assuming circular symmetry, as a
function of radius) over a period of ten days after an
initial cartilage injury. Figure 5 corresponds to the cas-
cade of events illustrated in the left hand arrows of
figure 2, while figure 6 corresponds to the right hand
arrows of figure 2. The initial conditions correspond to
the presence of an initial injury, i.e. a population of
necrotic cells occupying a circle of radius 0.25 mm.
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Figure 5 Healthy and Penumbra cells without EPO.T h i sf i g u r es h o w st h ee v o l u t i o no ft h eh e a l t h ya n dp e n u m b r a( c o m p r i s e do fb o t h
catabolic and EPOR active) cell population densities over a period of 10 days. The results shown here correspond to a situation in which there is
no production of or response to EPO. We see here that the healthy cell population is decimated. In accord with figure 4 and the corresponding
mathematical model (equations (3-11)) this is due to the uninhibited influence of pro-inflammatory cytokines.
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Page 10 of 15Following the initial injury there is a quick and steady
increase in the population density of catabolic and
EPOR active cells and decline in the population density
of healthy cells (figures 5(b)-(i)). After ten days there
has formed a thick penumbra of catabolic cells which
a r eb e g i n n i n gt od i eo f f( v i aa p o p t o s i s ,s e ef i g u r e5 ( i ) )
s h o w i n gt h a tw i t h o u tt h ep r e s e n c eo fE P Ot h e r ei s
unlimited secondary pro-inflammatory cytokine-induced
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(i)t=10 days
Figure 6 Healthy and Penumbra cells with EPO. This figure shows the evolution of the healthy and penumbra cell population densities over
a period of 10 days. Initially there is the development of a population of penumbra cells (c) due to the time lags for EPO production and EPOR
activation. However, once healthy cells at the edge of the penumbra begin to produce EPO and penumbra cells become EPOR active there is
an increase in the population density of healthy cells near the injury and there ceases to be expansion of the penumbra ((d) - (i)).
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Page 11 of 15injury and unabated spread of the cartilage lesion. This
corresponds qualitatively well with the expected results
illustrated in figure 2(d), (e).
Figure 6 shows the time evolution of chondrocyte
population density (per area, and assuming circular sym-
metry, as a function of radius) over a period of ten days
after an initial cartilage injury with the antagonistic
effects of EPO on TNF-a. The initial conditions are the
same as previously described for the simulations without
EPO. The dynamics of the chondrocyte cell states popu-
lation densities are the same over the first day or so as
in the case with no EPO. This is due to the time delays
for cells to become EPO producing and EPOR active.
However, we see by day 3 or so (see figure 6(d) and
compare with 6(d)) there is a significant difference in
the population dynamics compared with that in the no
EPO case. We begin to see a reversion of cells in the
EPOR active state back to the healthy state. While there
is still some amount of secondary injury due to the
inflammatory process and presence of pro-inflammatory
cytokines, there is a fixed radius (see figures 6(f)-(i))
beyond which the penumbra, and hence the lesion and
secondary proinflammatory cytokine induced injury,
cannot expand. Thus there is lesion abatement by the
action of the anit-inflammatory cytokine EPO. This cor-
responds qualitatively well with the expected results illu-
strated in figure 2(d*), (e*).
Now we describe the behavior of the model under
small changes to the parameter values. In order to do so
we vary the parameters one at a time for a small range
and observe how this effects the behavior of the healthy
and penumbral cells. This exploration of the parameter
space gives some indication of which parameters domi-
nate the dynamical behavior for the model equations.
For a given parameter z we vary the value over a range
of [0, 2z], with the exception of lR, lM, lF, lP, a which
must be strictly positive. Here we focus on those para-
meters associated with nonlinear terms in the model
equations. Table 3 summarizes the results described in
what follows. Note that below and in table 3 when we
say “robust” we mean that the qualitative behavior of
the simulations in unchanged as the parameter value is
varied. We first consider varying the values of sR, sM,
sF, sP, i.e. the production rates for each of the four che-
mical species. For both the production of ROS, sR,a n d
the production of EPO, sP, decreasing these values leads
to simulations which steadily approach the case with no
EPO. That is, lesion expansion becomes more and more
pronounced until inflammation and secondary cytokine
induced injury become unchecked. This behavior is as
to be expected. In contrast, increasing the values for
these two parameters results in the abatement of lesion
expansion at earlier times. Increasing or decreasing the
production rate, sF of TNF-a has the exact opposite
behavior to increasing or decreasing sR or sP. For posi-
tive values of the production rate of DAMPs, sM,t h e
long term behavior of the simulations are stable. This is
because the principal role of alarmins is to initiate
inflammation and thus are most influential for early
time. Setting sM = 0 results in no inflammation which
Table 3 Response of cells to small perturbations in parameter values
Response of cell behavior to small changes in parameter values
Parameter Response to increase in value Response to decrease in value
sR Lesion expansion is abated sooner Steadily approaches no EPO case
sM Robust Robust, until aM = 0 when no inflammation occurs
sF Lesion abatement becomes less efficient Lesion expansion is abated sooner
sP Lesion expansion is abated sooner Steadily approaches no EPO case
Λ Robust Robust (must have Λ >0 )
lR Lesion abatement becomes less efficient Lesion expansion is abated sooner
lM Lesion expansion is abated sooner Steadily approaches unabated lesion expansion
lF Lesion expansion is abated sooner Lesion abatement becomes less efficient
lP Robust Robust
a Robust Penumbra becomes more vigorous but smaller in radius
b1 Lesion abatement becomes less efficient Formation of penumbra steadily decreases
b2 Robust Robust
g Robust Penumbra becomes more vigorous but smaller in radius
ν Robust Robust
μSA Robust Robust
μDN Robust Robust
This tables summarizes the results of the parameter study described in the main body of the text. When we say “robust” we mean that the qualitative behavior
of the simulations in unchanged as the parameter value is varied.
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tures of the simulations which occur when the values of
a,a n dg are decreased. As the values of these two para-
meters are decreased, we observe the formation of a
penumbra of smaller and smaller radius. However, the
cells forming the penumbra are much slower to respond
to EPO. This makes sense for the parameter a since this
is the rate at which EPOR active cells convert back to
the healthy state. On the other hand, g is the rate at
which catabolic cells switch to the EPOR active state. In
this case, small values of g correspond to a situation in
which the penumbra is made up of predominantly cata-
bolic cells which do not respond to EPO. We note that
increasing lR, lF has the same effect as decreasing sR,
sF and similar for decreasing lR, lF.A l s ov a r y i n glM
has an expected effect since it is the saturation constant
for DAMPs. Finally, the other parameters are robust as
noted in table 3.
Conclusions
Based on the biological assumptions summarized in the
diagram shown in figure 2 we have developed a mathema-
tical representation of some of the principal features of the
injury response in articular cartilage. In particular we have
captured, qualitatively, secondary pro-inflammatory cyto-
kine induced injury and lesion based on the balance
between TNF-a and EPO as described in Brines and Cer-
mani [5]. This modeling effort suggests that anti-inflam-
matory cytokines may act in such a way as to influence
the response of chondrocytes to alarmins and pro-inflam-
matory cytokines. In particular sufficient concentrations of
antiinflammatory cytokines may limit healthy chondro-
cytes conversion to the catabolic state. Provided dosages,
dosage responses, delivery method, etc. the model (equa-
tions (3-11)) can be applied to study the effectiveness of
the introduction of exogenous EPO as a potential therapy
for limiting secondary pro-inflammatory cytokine induced
injury and promoting healing in articular cartilage. We
note however, that due to the time delays for cells to
become EPOR active, there is little or no response to EPO
at early times after an injury has occurred. Thus there is a
window of time during which introduction of tissue-pro-
tective EPO derivatives such as discussed in [5] are ineffec-
tive as therapies. This is evidenced by comparing figures 5
(a)-(b) with figures 6(a)-(b) in which there is little or no
difference between the case with EPO and the case with-
out. The model presented herein also has potential appli-
cations for studying other issues related to post-traumatic
stress in articular cartilage. By coupling this model with
mechanical models, or including geometric features of car-
tilage one may be able develop a more complete theoreti-
cal description of aspects of cartilage injury of relevance in
the biomedical sciences.
Reviewer Comments and Responses
Reviewer number 1: Yang Kuang
The authors claim to present a minimal mathematical
model based on known mechanisms to investigate the
spread and abatement of such lesions. This is debatable
as the model involves both diffusion and time delay yet
the simulation does not address the spatial structure.
The simulated dynamics is rather simple which suggests
that some simple nonlinear system of ODEs may gener-
ate comparable outcomes. While modeling anything bio-
logical of this complexity will inevitably involve many
simplifying assumptions and even the plausible models
are ad hoc, I think the authors can present much more
details on their model formulation and validation. Why
can not some simple ODE models accomplish what they
did here? The authors mentioned that specific functional
forms appearing in their model system (equations (3-
11)) have been chosen to capture the critical thresholds
and represent the function shapes qualitatively. Later
the authors refer that information as figure 2 which is
hardly illustrative for thresholds or function shape. It is
also important to provide meaningful parameter estima-
tion and the source of information or the lack of it.
Response to review 1:
Reviewer 1 mentions that the simulated dynamics do
not address the spatial structure, but the simulations
(Figures 5 and 6) show time slices of radial profiles cell
populations which corresponds to the radial expansion
of a lesion. Thus the authors believe that the simula-
tions do address spatial structure. Moreover, diffusion of
cytokines is the principal mechanism driving the expan-
sion of lesions in articular cartilage injuries so that omit-
ting diffusion ignores a principal mechanism behind one
of the facets of cartilage injury response that is of pri-
mary interest. We would also like to clarify the inclusion
of time delays in our model. Delays are included since,
as described in the biological literature, there are time
lags between when cells are signaled to become either
EPOR active and/or EPO producing. By using delay
terms rather than ODE’s that capture the lesion abate-
ment process phenomenologically, we maintain a clear
connection between model parameters and the underly-
ing physiology.
Reviewer 1 brings up a concern regarding the parame-
trization of the model. Reviewer 2 also has similar con-
cerns so we address both simultaneously. First, in the
r e v i s e dm a n u s c r i p tw eh a v ep r o v i d e dat a b l el i s t i n gt h e
parameter values for the mathematical model used in
the simulations. A small number of these parameters
have been determined from literature which is cited in
the revised manuscript. The remaining parameters have
been approximated to give reasonable results. By this we
mean cell population densities and chemical
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Page 13 of 15concentration levels that are consistent with those
observed in other, but not necessarily injury related, car-
tilage experiments. Also we choose approximated para-
meter values that give lesion expansion and abatement
occurring over a time frame as is observed experimen-
tally. Second, one of the goals of our model is to provide
a conceptual framework for the orthopaedics commu-
nity to understand this phenomena from the perspective
of cytokine interactions and determine what information
is missing, so that we can eventually have a truly
mechanistic understanding of lesion abatement. More-
over, we have attempted to develop a model that will
motivate additional experiments to determine para-
meters, since to our knowledge many of the parameter
values for this type of mechanistic model have yet to be
carried out. We feel that it is of value to have these
parameter values determined experimentally rather than
employing statistical parameter estimation techniques.
The level of additional parametrization called for in this
modeling effort is consistent with other similar models
in the literature, for an example see the recent article
[14].
Reviewer number 2: James Faeder
Summary
This paper presents a model of inflammation and tissue
damage in cartilage. The model considers secretion and
diffusion of soluble inflammatory and anti-inflammatory
mediators and their effects on tissue, which is modeled
as a set of spatial continuum variables. Time courses of
tissue populations (healthy vs. dead or damaged cells)
are determined for two different scenarios starting from
the same initial damage - first with negative feedback
from anti-inflammatory mediators and second with anti-
inflammatory mediators. The simulations show that
negative feedback from anti-inflammatory mediators is
necessary for recovery of damaged tissue to occur. Some
experimental results from cell culture experiments are
presented in the Background section and show that
some effects of inflammation can be mitigated by EPO,
which provides support for a key assumption of the
model. Major comments 1) Missing parameters.
Although the structure of the model is reasonably well
described, unless I somehow missed them model para-
meters are not given in the paper. This should be
required for publication. Parameters need to be provided
along with some discussion of how they were chosen
and references supporting those choices. 2) The results
seem very preliminary. No attempt is made to compare
the results of the simulation with experiments. Results
are only presented for two scenarios and no characteri-
zation of the effect of varying model parameters is
given. Have wound recovery experiments been per-
formed, for example, in which the anti-inflammatory
response is somehow manipulated - either enhanced or
suppressed? Can the behavior of the model be modu-
lated by changing various parameters that could either
vary or be manipulated in actual wounds? The main
point seems to be that without anti-inflammatory
responses acting as a negative feedback, the inflamma-
tory response, which has built-in positive feedbacks, will
proceed unchecked. Although it is useful to a degree to
demonstrate that the expected behavior does occur for a
realistic model (something that has not completely been
shown here because of point (1)), I think that is just the
jumping off point for a reasonable model and does not
by itself justify publication. As the paper stands cur-
rently, I do not think there is enough here to warrant a
journal publication. Minor comments p. 2. The back-
ground starts immediately with presentation of results
in Figure 1 without sufficient motivation. p. 4. “We
assume chondrocytes become necrotic only at the time
of an initial injury.” What is the basis for this assump-
tion? p. 5 and Figure 4. The diagram is somewhat con-
fusing. TNF-alpha is shown as stimulating ECM,
whereas in the model it stimulates degradation of ECM.
Why are the DAMPs released by ECM degradation
shown only as increasing apoptosis of ST cells and not
also of healthy cells (or EPOR active cells). p. 6. Eq. 6. Is
the mathematical form of the delay equation correct for
the physical scenario? The production of EPO at the
current time is assumed to be proportional to the popu-
lation of healthy cells at a time τ2 earlier (taken to be 24
hours), but what if the healthy cell population is rapidly
decaying during that time? It would seem that the
healthy cells that become catabolic cells should not be
producing EPO. p. 8. Solution of partial differential
equations for system with circular symmetry. References
given are for numerical solution of ordinary diff. eqs.,
but the scheme for solving the PDEs is not described. A
one or two sentence description and a reference should
be given for the scheme used.
Response to review 2:
As reviewer 2 points out, the experimental results dis-
cussed in this manuscript are presented in the back-
ground without motivation. In the revised manuscript
we have tried to briefly motivate these results.
Reviewer 2 has asked for a justification for our
assumption that chondrocytes become necrotic only at
the time of initial injury. Our statement in the manu-
script quoted by reviewer 2 is a little ambiguous. What
we meant is that the initial injury results in cell death
through necrosis, while secondary cytokine-induced
injury results in cell death through apoptosis. While
these may be simplifying assumptions, it is not entirely
clear which type of cell death dominates in osteoarthri-
tis. Moreover, we have provided an additional reference
to lend some support to our assumptions and have
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Page 14 of 15clarified the quoted statement in the manuscript with a
more detailed discussion.
Reviewer 2 has pointed out that Figure 4 is somewhat
confusing, in that it is difficult to tell from the diagram
that TNF-a degrades the extracellular matrix (ECM).
Although, it is clearly stated in the caption to that figure
that this is the case, and the mathematical model
r e f l e c t st h ef i g u r ei sc o n f u s i n g .W eh a v em o d i f i e dt h e
diagram shown as Figure 4 in the manuscript to try to
make it more clear that extracellular matrix is not sti-
mulated by TNF-a but is a “catalyst” of sorts of DAMPs
due to degradation of ECM by TNF-a.D A M P si n f l u -
ence cells in different states in different ways. DAMPs
do not cause healthy cells to enter directly into apopto-
sis. Healthy cells signaled by alarmins must first become
“sick”, i.e. catabolic, before they can enter into apoptosis.
Reviewer 2 has pointed out an error in the form of the
production term for EPO. The production of EPO
should be proportional to the healthy cell population at
the current time, not at a τ2 earlier time. We have modi-
fied the equations in the revised manuscript and carried
out and included new simulations. The results are quali-
tatively the same, however in the second scenario it
takes a slightly longer time for lesion abatement to
occur since there are fewer (at least near the wound)
healthy cells to produce EPO. We note that in the first
scenario we take EPO production to be zero so that
there is no different from the results in the previous ver-
sion of the manuscript.
Reviewer 2 has pointed out that we neglected to
describe the scheme for discretizing the partial differen-
tial equations that make up our mathematical model in
carrying out numerical simulations. We have addressed
this by stating the scheme used and providing a refer-
ence for this scheme.
Reviewer 3: Anna Marciniak-Czochra
Provided no comments for publication.
Acknowledgements
This work was supported by the National Science Foundation grant number
DMS-0914514 and by the National Institutes of Health Challenge grant
number 1 RC1 AR058403-01.
Author details
1Department of Mathematics/Program in Applied Mathematical and
Computational Sciences, University of Iowa, Iowa City, Iowa, USA.
2Department of Orthopaedics and Rehabilitation, University of Iowa Hospitals
and Clinics, Iowa City, Iowa, USA.
Authors’ contributions
All authors read and approved the final manuscript. JMG carried out the
simulations and drafted the manuscript. JMG BPA PSR JAM developed the
mathematical model and interpreted the results of the simulations. LD
performed cell blot experiments.
Competing interests
The authors declare that they have no competing interests.
Received: 27 September 2011 Accepted: 21 February 2012
Published: 21 February 2012
References
1. Buckwalter J, Mow V, Ratcliffe A: Restoration of injured of degenerated
articular cartilage. J Am Acad Orthop Surg 1994, 2(4):192-201.
2. Freedman K, Coleman S, Olenac C, Cole B: The biology of articular
cartilage injury and the microfrac-ture technique for the treatment of
articular cartilage lesions. Sem Arthroplasty 2002, 13(3):202-209.
3. Goodwin W, McCabe D, Sauter E, Reese E, Walter M, Buckwalter J, Martin J:
Rotenone prevents impact-induced chondrocyte death. J Orthop Res
2010, 28(8):1057-1063.
4. Ramakrishnan P, Hecht B, Pedersen D, Lavery M, Maynard J, Buckwalter J,
Martin J: Oxidant conditioning protects cartilage from mechanically
induced damage. J Orthop Res 2010, 28(7):914-920.
5. Brines M, Cerami A: Erythropoietin-mediated tissue protection: reducing
collateral damage from the primary injury response. J Intern Med 2008,
264:405-432.
6. Harris HE, Raucci A: Alarming news about danger. EMBO Reports 2006,
7(8):774-778.
7. Bianchi ME: DAMPs, PAMPs and alarmins: all we need to know about
danger. J Leukoc Biol 2006, 81:1-5.
8. Del Carlo M, Loeser RF: Cell Death in Osteoarthritis. Curr Rheumatol Rep
2008, 10(1):37-42.
9. Ayati BP: Methods for computational population dynamics ProQuest LLC,
Ann Arbor, MI; 1998, [Thesis (Ph.D.)- The University of Chicago].
10. Shampine LF, Reichelt MW: The MATLAB ODE suite. SIAM J Sci Comput
1997, 18:1-22.
11. Shampine LF, Thompson S: Solving DDEs in MATLAB. Appl Numer Math
2001, 37(4):441-458.
12. Shampine LF, Thompson S: Numerical solution of delay differential
equations. 2009, 245-271.
13. Leddy Ha, Guilak F: Site-specific Molecular Diffusion in Articular Cartilage
Measured Using Florescence Recovery After Photobleaching. Ann.
Biomed eng 2003, 31(7):753-760.
14. Wang Y, Pivonka P, Buenzli PR, Smith DW, Dunstan CR: Computational
Modeling of Interactions between Multiple Myeloma and the Bone
Microenvironment. PloS one 2011, 6(11):e27494.
doi:10.1186/1745-6150-7-9
Cite this article as: Graham et al.: Reaction-Diffusion-Delay Model for
EPO/TNF-a Interaction in articular cartilage lesion abatement. Biology
Direct 2012 7:9.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Graham et al. Biology Direct 2012, 7:9
http://www.biology-direct.com/content/7/1/9
Page 15 of 15